-
2026-01-27
Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease
-
2026-01-23
Altamira Therapeutics Announces Market Approval of Bentrio Nasal Spray in China
- 1
Contact PR
